IBDEI1MU ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27314,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,27314,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,27315,0)
 ;;=E23.0^^132^1312^31
 ;;^UTILITY(U,$J,358.3,27315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27315,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,27315,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,27315,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,27316,0)
 ;;=E27.1^^132^1312^51
 ;;^UTILITY(U,$J,358.3,27316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27316,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,27316,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,27316,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,27317,0)
 ;;=E27.2^^132^1312^1
 ;;^UTILITY(U,$J,358.3,27317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27317,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,27317,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,27317,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,27318,0)
 ;;=E27.3^^132^1312^23
 ;;^UTILITY(U,$J,358.3,27318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27318,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,27318,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,27318,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,27319,0)
 ;;=E29.1^^132^1312^52
 ;;^UTILITY(U,$J,358.3,27319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27319,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,27319,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,27319,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,27320,0)
 ;;=E55.9^^132^1312^59
 ;;^UTILITY(U,$J,358.3,27320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27320,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,27320,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,27320,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,27321,0)
 ;;=E66.01^^132^1312^38
 ;;^UTILITY(U,$J,358.3,27321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27321,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,27321,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,27321,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,27322,0)
 ;;=E66.8^^132^1312^42
 ;;^UTILITY(U,$J,358.3,27322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27322,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,27322,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,27322,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,27323,0)
 ;;=E66.9^^132^1312^43
 ;;^UTILITY(U,$J,358.3,27323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27323,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,27323,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,27323,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,27324,0)
 ;;=E74.39^^132^1312^35
 ;;^UTILITY(U,$J,358.3,27324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27324,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,27324,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,27324,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,27325,0)
 ;;=E83.30^^132^1312^46
 ;;^UTILITY(U,$J,358.3,27325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27325,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,27325,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,27325,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,27326,0)
 ;;=E83.51^^132^1312^28
 ;;^UTILITY(U,$J,358.3,27326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27326,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,27326,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,27326,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,27327,0)
 ;;=E83.52^^132^1312^26
 ;;^UTILITY(U,$J,358.3,27327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27327,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,27327,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,27327,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,27328,0)
 ;;=E87.5^^132^1312^27
